Stay updated on Ribociclib vs Bevacizumab in First-Line Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Ribociclib vs Bevacizumab in First-Line Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ribociclib vs Bevacizumab in First-Line Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed. This is a metadata update and does not affect the displayed trial details.
    Difference
    0.0%
    Check dated 2026-03-19T05:09:27.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3 and the v3.4.2 label was removed.
    Difference
    0.0%
    Check dated 2026-03-12T01:41:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page displays Revision: v3.4.2 and removes the previous notice about government funding/operating status as well as Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T12:18:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:36:07.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    UI updates include Show glossary and new metadata labels Last Update Submitted that Met QC Criteria and No FEAR Act Data with Revision: v3.4.0. The previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:31:53.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Footer revision updated to Revision: v3.3.4, replacing v3.3.3; this does not alter trial details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:32:33.000Z thumbnail image

Stay in the know with updates to Ribociclib vs Bevacizumab in First-Line Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ribociclib vs Bevacizumab in First-Line Metastatic Breast Cancer Clinical Trial page.